CN Stock MarketDetailed Quotes

002728 Teyi Pharmaceutical Group

Watchlist
  • 9.63
  • +0.09+0.94%
Market Closed Dec 13 15:00 CST
4.92BMarket Cap69.78P/E (TTM)

Teyi Pharmaceutical Group Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Teyi Pharmaceutical Group Q3 2024 Earnings Date

Currency：CNYOct 26, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
--
141.85M
--
-31.44%
EPS
--
0.01
--
-87.50%
Analyst Rating
Strong Buy

Dec 13, 2024

Teyi Pharmaceutical Group Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
Mar 8, 20242023/FY1.067B / 1.151B--
DatePeriodRevenue/EstimateEarnings Call
Mar 8, 20242023/FY1.067B / 1.151B--

Teyi Pharmaceutical Group Earnings Reports

  • Teyi Pharmaceutical: Report for the third quarter of 2024

    Oct 25 12:00 ET

  • Teyi Pharmaceutical Group: Summary of Half-Year Report in 2024.

    Jul 25 12:00 ET

  • Teyi Pharmaceutical Group: Half-year report for the year 2024.

    Jul 25 12:00 ET

  • Teyi Pharmaceutical Group: 2024 Interim Performance Forecast

    Jul 8 12:00 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Dec 13, 2024

    Strong Buy

    • Strong Buy

      66.67%

    • Buy

      33.33%

    • Hold

      0.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    CN
    Overall
    Symbol
    Price
    % Chg

    No Data

    Investment Theme Macrobiotic NMN
    Macrobiotic NMN
    Intraday-1.69%